	Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer. Front Pharmacol Shen H, Huang S, Zhang J. PMID: 42239517 [PubMed - in process]
	A comparative study of oral and gut microbiota for differentiating benign pulmonary nodules from lung cancer. Front Microbiol Zhao Z, Zhao S, Liu F, Li G, Hu X, Li L. PMID: 42238890 [PubMed]
	Evaluation of kidney stone-related renal infection status by 18F-FDG PET/CT in lung cancer patients with concomitant nephrolithiasis: a multicenter study. Front Immunol Yao X, Ying X, Liu H, Duan C, Li B, Hao Z, Ye Z, Xu H, Mei H, Liu H, Liu J. PMID: 42238574 [PubMed - in process]
	Targeting non-small cell lung cancer: Molecular mechanisms and clinical studies (Review). Oncol Lett Luo Y, Yin G, Luo X, Liu Y, Jin K, Wang Z. PMID: 42238008 [PubMed]
	Effectiveness of carboplatin vs cisplatin in lung cancer chemo-immunotherapy: A systematic review and meta-analysis. Tumori Leonetti A, Maglietta G, Peroni M, Diodati F, Dodi A, Mazzaschi G, Perrone F, Caminiti C, Tiseo M. PMID: 42237664 [PubMed - as supplied by publisher]
	Landscape of Chinese Lung Cancer Patients With Compound Mutations and Acquired Resistance Alterations: A Retrospective Study. Int J Cancer Huang M, Yang J, Peng P, Wang Y, Song L, Lin Y, Zhao J. PMID: 42237450 [PubMed - as supplied by publisher]
	Robotic vs thoracoscopic vs open lobectomy and segmentectomy for lung cancer: a multicenter cohort study in the ATS of Milan. J Robot Surg Mazzali C, Buzzoni C, Grignani F, Incarbone MA, Marulli G, Nosotti M, Pariscenti GL, Pastorino U, Spaggiari L, Veronesi G, Russo AG, THOR-ATS (Thoracic Health Outcomes Research) Group. PMID: 42237053 [PubMed - in process]
	A novel ensemble-based genetic algorithm for enhanced feature selection in lung and pancreatic cancer diagnosis. Discov Oncol Shabir S, Chishti MA. PMID: 42237052 [PubMed - as supplied by publisher]
	The evolution of non-surgical management in stage III non-small cell lung cancer. BJC Rep Patel MS, Hammond A, Dee EC, Iyengar P. PMID: 42236951 [PubMed]
	The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer. Sci Rep Xu Q, Deng Y, Cai Y, Yu S, Kang M, He F. PMID: 42236852 [PubMed - as supplied by publisher]
	A comprehensive analysis and visualization of immune-related adverse events in lung cancer immunotherapy a bibliometric study. Discov Oncol Li X, Zhang F, Xu X. PMID: 42236618 [PubMed - as supplied by publisher]
	Burden of COPD and lung cancer attributable to household air pollution in Morocco: a secondary analysis using population attributable fractions. BMJ Open El Harch I, Mahfoudi H, Benmaamar S, Tachfouti N, El Rhazi K. PMID: 42236099 [PubMed - in process]
	Uncertainty quantification framework for AI-based survival models: Application to lung cancer prognosis in older adults for informed decision-making. Artif Intell Med Lee D, Tran TN, Jeong J, Kwon H, Cho H. PMID: 42235349 [PubMed - as supplied by publisher]
	Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab. Lung Cancer Ikeda S, Kenmotsu H, Koto R, Hirai T, Ogi M, Sato Y, Iwao C, Kitagawa H, Yamamoto N. PMID: 42235163 [PubMed - as supplied by publisher]
	Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators. J Clin Oncol Doroshow DB, Leal TA, Waqar SN, Borghaei H, Camidge DR, Dragnev KH, Edelman MJ, Gandara DR, Gerber DE, Gray JE, Hirsch FR, Husain H, Kozono DE, Leighl NB, Li BT, Mack PC, Neal JW, Paik PK, Patel SP, Riess JW, Redman MW, Reckamp KL. PMID: 42234933 [PubMed - as supplied by publisher]
	Complex versus simple segmentectomy in non-small cell lung cancer: a single-center, retrospective study. Gen Thorac Cardiovasc Surg Seto K, Matsubayashi Y, Noritake O, Matsui T, Suzuki S, Kuroda H, Masago K, Sakakura N. PMID: 42234389 [PubMed - as supplied by publisher]
	Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer. Per Med Guo H, Li J, Li T, Ruan J. PMID: 42233655 [PubMed - as supplied by publisher]
	Extracellular Vesicles in Exhaled Breath Condensate as Emerging Biomarkers in Lung Cancer. Am J Physiol Cell Physiol Schmidt B, Tambon C, Cortopassi F, Bokemeyer C, Saul MJ. PMID: 42233525 [PubMed - as supplied by publisher]
	Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study. Future Oncol Chen Z, Yang F, Jiang Z, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Moore AC, Lu S. PMID: 42233228 [PubMed - as supplied by publisher]
	Tumor immune microenvironment in non-small cell lung cancer progression. Front Immunol Jiang J, Zhong M, Wang J, Zhang Z, Li W, Deng Z. PMID: 42233035 [PubMed - in process]

Articles 1 - 20 / 159220

Page 1 of 7961



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy